The role of neutralizing antibodies to interferon-β as a biomarker of persistent MRI activity in multiple sclerosis: a 7-year observational study
Crossref DOI link: https://doi.org/10.1007/s00228-016-2073-6
Published Online: 2016-06-01
Published Print: 2016-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Paolicelli, Damiano
Manni, A.
Iaffaldano, A.
Di Lecce, V.
D’Onghia, M.
Iaffaldano, P.
Trojano, M.
License valid from 2016-06-01